Last reviewed · How we verify
NCT03443882
Bioavailability of Astaxanthin Formulations
EARLY_PHASE1 trial testing Astaxanthin in Healthy Volunteers in 10 participants. Status unknown.
2 May 2019
Quick facts
| Lead sponsor | Algatechnologies Ltd. |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 10 |
| Start date | 25 March 2018 |
| Primary completion | 2 May 2019 |
| Estimated completion | 30 May 2019 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Astaxanthin — full drug profile →
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
Algatechnologies Ltd.
Who can join
Adults 21 to 50, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bioavailability of dietary supplement formulations in healthy volunteers after a single oral dose.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03443882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Astaxanthin
Trials testing the same drug.
- NCT07509970 — Effects of Astaxanthin Supplementation on Soccer Performance Under Fatigue · NA · completed
- NCT06460181 — Impact of Astaxanthin on Cognition in Recreationally Active Females · Phase 4 · recruiting
- NCT06429059 — ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) · Phase 2 · completed
- NCT05138549 — Astaxanthin for Management of Inflammation in Knee Osteoarthritis · Phase 2, PHASE3 · terminated
- NCT05376501 — A Study to Evaluate the Effect of Astaxanthin in Healthy Participants · NA · completed
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other Algatechnologies Ltd. trials
Trials by the same sponsor.
- NCT03625284 — Oral Dietary Fucoxanthin Rich Supplement for Liver Health · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03443882 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Algatechnologies Ltd.
- Last refreshed: 21 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing